From professional translators, enterprises, web pages and freely available translation repositories.
reduce the time to reach clinical proof of concept in immunological, respiratory, neurological and neurodegenerative diseases;
reduce the time to reach clinical proof of concept in immunological, respiratory, neurological and neurodegenerative diseases
Last Update: 2017-04-07
Usage Frequency: 1
Quality:
[7] pokyn výboru pro veterinární léčivé přípravky (cvmp): environmental risk assessment for veterinary medicinal products other than gmo containing and immunological products (emea/cvmp/055/96-final) guidelines on environmental impact assessment (eias) for veterinary medicinal products – phase i and ii (cvmp/vich/592/98-final; cvmp/vich/790/03-final http://www.emea.eu.int).
[7] (leitlinie des ausschusses für tierarzneimittel) (cvmp) note for guidance: environmental risk assessment for veterinary medicinal products other than gmo containing and immunological products (emea/cvmp/055/96-final) guidelines on environmental impact assessment (eias) for veterinary medicinal products – phase i and ii (cvmp/vich/592/98-final; cvmp/vich/790/03-final http://www.emea.eu.int)
Last Update: 2014-10-23
Usage Frequency: 6
Quality:
